DALLAS, TX and IRVINGTON, NY--(Marketwired - February 25, 2014) -
| Highlighted Links |
|
|
MELA Sciences, Inc. (NASDAQ: MELA), developer of MelaFind®, an FDA approved optical diagnostic device that assists dermatologists in melanoma diagnosis, announced that its CEO Rose Crane will be interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio’s The Traders Network. All interested investors and prospective customers across the US are encouraged to tune in and listen live via Clear Channel’s nationally syndicated iHeart Radio stream.
The live interview details are as follows:
Date: Today, Tuesday, February 25, 2014
Start Time: 1:05pm CST | 11:05 am PST | 2:05 pm EST (U.S.)
Network: Clear Channel
Station: DFW 1190AM Dallas-Ft. Worth
Host: Michael Yorba
Live Radio Stream: http://www.iheart.com/live/4276/?autoplay=true
About Clear Channel: Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. www.clearchannel.com.
About Michael Yorba: Mr. Yorba is the founder of Yorba Media and featured host on Clear Channel. For the past six years he has been integrally involved with producing and hosting a daily talk show called Commodity Classics, and The Traders Network.
From the fast action of the trading pit... to the power brokers making the headlines... Michael Yorba interviews the front-page Titans about the latest in capital markets, CEO milestones, trading tools, real estate acquisitions and market trends. Learn how the experts use risk management techniques to build fully diversified portfolios and what it takes to put up big board earnings. It’s a fast moving, high-energy show that presents stocks, commodities, bonds, forex, derivatives, real estate, political trends, technology trends, crowd funding and impact investment insights in a new light and keeps investors and consumers asking for more... The Traders Network stays ahead of the curve by featuring leading market and business professionals, sophisticated technology, and the analytics needed to identify the most lucrative investment strategies. Successful performance depends on finding the right opportunities. So... shift your thinking and join us as we deliver “tomorrow’s ideas today” on Clear Channel’s The Traders Network Monday - Friday from 1:00pm - 3:00pm CST live after Glenn Beck.
About MELA Sciences, Inc. (www.melasciences.com)
MELA Sciences is a medical device company developing dermatology diagnostics utilizing state-of-the-art optical imaging. The flagship product is MelaFind®, an FDA, PMA and CE Mark approved, non-invasive diagnostic tool to aid dermatologists in melanoma evaluation and diagnosis. MelaFind® uses a variety of visible to near-infrared light waves to evaluate skin lesions from the surface to 2.5 mm beneath the skin. It provides images and data on the relative disorganization of a lesion’s cell structure that provides substantial additional perspective to aid melanoma diagnosis. MELA is also exploring new potential uses for its core imaging technology and algorithms.
Twitter: MELASciencesIR or MelaFind
Facebook: MelaFind
StockTwits: MELASciencesIR
BoardVote: MELA Sciences
A www.1800PublicRelations.com PR Event
Contact:
Media
MELA Sciences, Inc.
Diana Garcia Redruello
212-518-4226
dgarcia@melasciences.com
or
Investors
Catalyst Global
Toni Trigiani, David Collins
212-924-9800
mela@catalyst-ir.com
Press/Media Contact:
Matthew Bird
MUNCmedia Public Relations
+1 (917) 409-8211
matt.bird@muncmedia.com
www.muncmedia.com
Help employers find you! Check out all the jobs and post your resume.
